Plain-English translation of NCT07491107 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that tracks patients who receive the Inspiron EVO stent, a new device designed to open blocked coronary arteries in people with complex or severe blockages. Researchers will collect information about your health, the procedure, and your recovery over 12 months to understand how well this treatment works in real-world situations.
Coronary artery disease can be especially difficult to treat when blockages are very long, heavily calcified, or affect multiple vessels. This study aims to gather real-world evidence about whether this newer stent design works safely and effectively for these more challenging cases.
You likely qualify if…
You likely don't qualify if…
You will receive the Inspiron EVO stent as part of your standard cardiac care. After your procedure, you will be asked to return for follow-up visits over the next 12 months so researchers can collect information about your symptoms, test results, and how you are recovering. Your doctors will use imaging technology during your procedure to carefully document how the stent is placed.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Brazil
Sponsor
Scitech Produtos Medicos SA
Enrollment target
~2,000 participants
Started
October 2026
Primary completion
October 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marco Aurélio A Costa, MD, PhD
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.